Delayed phase of hematoporphyrin-induced phototoxicity: modulation by complement, leukocytes, and antihistamines.
We have investigated the role of complement, leukocytes, and histamine in the delayed phase of hematoporphyrin-induced phototoxicity in guinea pigs. The phototoxic response was quantified by the accumulation of intravenously injected [125I]bovine serum albumin in the skin. There was a greater than 6-fold increase in the vascular response at the completion of irradiation, which subsided partially to reach a plateau of twice the preirradiation level between 0.5 h and 12 h. At 18 h, the vascular responsiveness returned to the baseline value. The 7 h timepoint was selected in this study to evaluate the modulation of the delayed phase. In complement-depleted guinea pigs, as well as in leukopenic animals, the enhancement in the vascular response was significantly suppressed (p vs control, less than 0.0001 and 0.0022, respectively). Cimetidine, when administered prior to irradiation, significantly suppressed the phototoxic response (p vs control, 0.0365). The combination of diphenhydramine and cimetidine, administered 6 h after the induction of phototoxicity, also suppressed the vascular response (p vs control, less than 0.0001). These data indicate that the expression of the delayed phase of hematoporphyrin-induced phototoxicity, similar to the early phase, requires the presence of an intact complement system, leukocytes, and histamine.
Lim
H W
HW
Young
L
L
Hagan
M
M
Gigli
I
I
D000818:Animals; D002927:Cimetidine / Q000008:administration & dosage / Q000627:therapeutic use; D003165:Complement System Proteins / Q000172:deficiency / Q000502:physiology*; D004155:Diphenhydramine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006168:Guinea Pigs; D006415:Hematoporphyrins / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007962:Leukocytes / Q000502:physiology*; D007970:Leukopenia / Q000150:complications; D010787:Photosensitivity Disorders / Q000139:chemically induced / Q000188:drug therapy / Q000276:immunology*; D011830:Radiation Effects
D006415:Hematoporphyrins; D006634:Histamine H1 Antagonists; D002927:Cimetidine; D004155:Diphenhydramine; D003165:Complement System Proteins